Loading
Call today: (636) 946-1650
Request an Appointment

From the Doctor's Desk

Article Content Return To Library

FDA Approves New Drug for COPD

Chronic obstructive pulmonary disease (COPD) is a devastating illness that causes difficulty breathing. There is no cure, and it can be hard to manage even with prescription medications. 

There is new hope for COPD sufferers for long-term disease management   A recently FDA-approved drug called Bevespi Aerosphere™ is the first of its kind to combine medications therapies to significantly increase lung function. Though it will not be able to treat asthma or relieve sudden breathing attacks like asthma, it will improve breathing with regular use.

The drug is a combination of two medications already in use for lung diseases. It is produced using a unique technology that allows for consistent dosing and uniform drug distribution throughout the lungs.  

AstraZeneca believes that the technology of this combination drug will help deliver better results for patients with COPD. During clinical trials, in over 3,700 patients with moderate to very severe COPD, Bevespi Aerosphere significantly improved lung function and reduced the need for rescue medications. Cough and urinary tract infections were the most common side effects. 

If you suffer from chronic obstruction of your airways or frequent breathlessness, talk to your doctor about improving your lung function with this exciting COPD treatment.

 

Copyright ©  - iHealthSpot, Inc. - www.iHealthSpot.com

This information is intended for educational and informational purposes only. It should not be used in place of an individual consultation or examination or replace the advice of your health care professional and should not be relied upon to determine diagnosis or course of treatment.